Contact Information
Address:
6135 Park S Dr suite 510, Charlotte, NC 28210
Phone:
Website
https://tmsofthecarolinas.com
TMS of the Carolinas in Charlotte NC is a clinical center specializing in NeuroStar® transcranial magnetic stimulation (TMS) therapy for treatment-resistant depression. Located at 6135 Park South Dr, Suite 510, Charlotte, NC 28210, the clinic offers non-invasive, FDA-cleared treatment protocols delivered in as little as 19-minute sessions, typically over a 7-week course.
6135 Park S Dr suite 510, Charlotte, NC 28210
https://tmsofthecarolinas.com
TMS of the Carolinas, located at 6135 Park S Dr Suite 510, Charlotte, NC 28210, is Charlotte's dedicated clinical center specializing in NeuroStar® transcranial magnetic stimulation (TMS) therapy. We are committed to providing advanced, non-invasive treatment options for individuals seeking relief from depression and other qualifying conditions within our Charlotte community.
At TMS of the Carolinas Charlotte location, we understand the significant impact mental health challenges can have on your daily life. Our team of experienced and compassionate healthcare professionals is focused solely on delivering the highest standard of care using the NeuroStar® TMS system. This FDA-cleared technology offers a drug-free alternative for patients who may not have responded adequately to previous treatments or prefer an option without medication side effects.
Our clinical approach at TMS of the Carolinas Charlotte is personalized. We begin with a thorough evaluation to determine if TMS is an appropriate treatment option for you. If it is, our team develops a customized treatment plan tailored to your specific needs and goals. Our state-of-the-art facility in Charlotte provides a comfortable and supportive environment throughout your TMS journey.
NeuroStar® TMS works by using focused magnetic pulses to gently stimulate specific areas of the brain responsible for mood regulation. This targeted approach helps restore balanced brain activity patterns, potentially leading to improved mood and overall well-being. The procedure is typically well-tolerated, requires no sedation, and allows many patients to return to their normal activities immediately following a session.
We pride ourselves on our Charlotte-specific expertise and our commitment to serving the residents of Charlotte seeking effective mental health treatment. Our team is readily available to answer your questions and determine if TMS therapy could be the next step in your mental wellness journey.
For more information about our services in Charlotte or to schedule a consultation, please visit our website at https://tmsofthecarolinas.com or call us at (803) 573-9748.
Frequently Asked Questions
Q1: What conditions does TMS of the Carolinas treat at our Charlotte location?
A1: Our Charlotte center primarily offers NeuroStar® TMS therapy for the treatment of Major Depressive Disorder (MDD). We focus our services specifically on helping Charlotte residents manage their depression.
Q2: Is TMS therapy at TMS of the Carolinas Charlotte location safe?
A2: Yes, NeuroStar® TMS is an FDA-cleared, non-invasive treatment with a favorable safety profile. We adhere strictly to safety protocols at our Charlotte facility to ensure a secure treatment experience for all patients.
Q3: How long does a typical TMS treatment session at TMS of the Carolinas Charlotte take?
A3: A standard TMS session at our Charlotte location typically lasts between 25 to 45 minutes. Most patients find they can return to their daily activities immediately following their appointment.
Q4: Do I need a referral to start TMS treatment at TMS of the Carolinas Charlotte?
A4: While not always required, we recommend scheduling an initial consultation where our Charlotte-based team can evaluate your condition and discuss whether TMS therapy is appropriate for you.
Q5: What is the success rate of TMS therapy for depression at TMS of the Carolinas Charlotte location?
A5: Research indicates that approximately 70% of patients treated with NeuroStar® TMS at our Charlotte center experience a significant reduction (at least 50%) in their depressive symptoms. Individual results may vary.